1. Pink Sheet

Strong House Vote On PBM, Generics Bill Sets Stage For Early 2024 Action

 
• By Sarah Karlin-Smith

Easy House passage of a health package that includes PBM reforms and policies to help generic drug makers likely creates enough momentum to spur bicameral action. Overall policy still a work in progress – presenting last-minute opportunities for other drug pricing reforms to get tacked on.

US Capitol building
The House of Representatives easily cleared a PBM reform bill on 11 December. • Source: Shutterstock

The US House of Representatives easily cleared a health care package that includes pharmacy benefit management reform and measures to help generic drug companies on 11 December, giving the policy goals a necessary momentum boost needed to help them hitch a ride on the government funding bill lawmakers will need to pass by 19 January 2024 to keep certain parts of the government open.

A Senate Finance Committee spokesperson told the Pink Sheet not to expect any Senate action on the topic before the upper chamber adjourns for the holidays, leaving H.R

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Pink Sheet

EU Shaping Biotech Act To Unleash SME Potential

 
• By Neena Brizmohun

European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.

New EU Filings

 
• By Neena Brizmohun

Brensocatib, Insmed's investigational treatment for non-cystic fibrosis bronchiectasis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.